In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing
John R. Sinnamon, Susan Y. Kim, Jenna R. Fisk, Zhen Song, Hiroyuki Nakai, Sophia Jeng, Shannon K. McWeeney, Gail Mandel
Abstract
mice with an adeno-associated virus expressing the hyperactive catalytic domain of adenosine deaminase acting on RNA 2 and Mecp2 guide. After 1 month, 50% of Mecp2 RNA is recoded in three different hippocampal neuronal populations. MeCP2 protein localization to heterochromatin is restored in neurons to 50% of wild-type levels. Whole-transcriptome RNA analysis of one neuronal population indicates that the majority of off-target editing sites exhibit rates of 30% or less. This study demonstrates that programmable RNA editing can be utilized to repair mutations in mouse models of neurological disease.
Topics & Concepts
RNA editingBiologyRNAMECP2PopulationGeneticsCell biologyGeneMedicineEnvironmental healthPhenotypeRNA regulation and diseaseRNA Research and SplicingCRISPR and Genetic Engineering